Business Wire

JUNIPER-NETWORKS

Share
Juniper Networks Announces Cloud Metro Innovation to Drive Sustainable Business Growth for Service Providers

Juniper Networks (NYSE: JNPR), a leader in secure, AI-driven networks, today announced the innovation that will power its vision and strategy for Cloud Metro – a new category of solutions for service providers, optimized for metro transformation and sustainable business growth. Traditional “retro” metro networks are device-centric and are buckling under the extreme scale, agility and experience demands that widespread digital transformation and the advent of 5G services are bringing .

Today’s announcement focuses on enabling sustainable business growth, with a series of high-performance networking systems, powered by AI-enabled, cloud-delivered automation, specifically designed to build next generation Cloud Metro infrastructure. These systems will deliver significantly-reduced natural resource consumption capabilities to help sustain the planet, improved tools and simplified working methods to help sustain over-pressured operations teams, along with embedded service assurance and security capabilities to optimize service experience, all while enabling service providers to sustain profitable business growth.

Juniper’s new Cloud Metro systems uniquely feature industry-leading energy-efficient, adaptive power designs as their foundational principle, enabling unused features and Packet Forwarding Engines (PFEs) to be automatically switched off when not in use. The removable modular power shelf design reduces e-waste and extends system lifetimes by accommodating up to 48 times bandwidth growth within the same chassis. It is certified as Titanium grade by CLEAResult® in its 80 Plus program , the first and only metro networking device power module to accomplish such a rating.

The future-proofed scale, capacity, performance and smart features of Juniper’s Cloud Metro portfolio replace the traditional 3-5 year ‘rip-and-replace’ network lifecycles with 7-12 year lifecycles. Pay-as-you-go models and a breadth of interface options allow service providers to flex their investment economically in line with demand.

Juniper’s advanced use of AI and cloud-delivered automation equips service providers to simplify day-to-day workflows, deploy services faster (with device onboarding taking just minutes instead of hours), reduce trouble tickets and accelerate time-to-service (and therefore revenue) restoration. This significantly improves productivity, empowering network engineers and operators to accomplish more, which is critical for employee satisfaction and retention.

The new solutions also deliver up to 71 percent lower Total Cost of Ownership (TCO) by leveraging the latest generation of silicon, industry-leading system design and AI-enabled Device Onboarding-as-a-Service. Zero Trust security is built-in rather than bolted-on, while active service assurance is embedded to deliver proactive service testing, monitoring and remediation.

Solution News Overview:

  • Juniper AI-Enabled Device Onboarding-as-a-Service is the first-use case to be launched leveraging Juniper Paragon Automation as a Service, driving real business outcomes by significantly reducing device onboarding times.
  • Juniper Networks™ ACX7000 Family ² products are sustainable, high-performance systems leveraging unique design and adaptive power innovations that deliver up to 77 percent lower power consumption, up to 64 percent better space efficiencies and 4-7 years longer system lifetime than leading competitive products available today. The portfolio also delivers the industry’s fastest router line card, highest 400GE density and fabric capacity per slot, up to 21.6 Tbps with 54x400GE ports, ready for 800G and beyond.
  • Juniper Paragon Active Assurance ³ test agents are embedded in JUNOS® OS Evolved, available in all ACX7000 models. This turns the cloud metro network into a distributed sensor for assuring user experience proactively which removes the need for additional, standalone probe hardware to be deployed. Additionally, with the new capability of emulating 5G UE/gNB, service providers can now simulate traffic for both the control plane and user plane, ensuring each 5G network slice meets expected SLA.
  • Zero Trust Security principles and the threat detection, analysis and prevention fundamentals of Juniper’s Connected Security portfolio have been applied throughout the Juniper Cloud Metro solution. Unique cryptographic digital identities are implemented with the Trusted Platform Module (TPM 2.0) across the Cloud Metro IP services fabric, enabling device attestation and RFC-compliant secure zero-touch provisioning (sZTP). In addition, file encryption and MACsec are implemented to protect data at rest and data in transit. This holistic approach to trust is further enhanced by Paragon’s ability to automatically validate the security deployment and operation across a network of ACX7000 devices.
  • Juniper Networks 400G ZR/ZR+ optics co-developed to reduce service provider costs by consolidating IP and optical layers with coherent pluggable optics, which eliminates an entire layer of DWDM transponder terminals by integrating 400G ZR/ZR+ Digital Coherent Optics (DCO). These optics fully comply with industry specifications from OpenZR+ and OIF .

Supporting Quotes

“In a world of 'retro metros,' Juniper’s new Cloud Metro solution stands apart. Our cloud-delivered Paragon Automation-as-a-Service promises immediate productivity increases for service providers. Instead of building complex, time-consuming 'DIY' automation solutions, they are empowered to focus on assuring service experiences for their customers. By extending our proven AI solution to the service provider WAN, we can improve productivity for customer operations teams by dramatically reducing trouble tickets and increasing network availability. And our extended ACX7000 Family delivers the most secure, assured, scalable and intelligent Cloud Metro portfolio on the market. This is the answer to service provider needs for a sustainable future for their profits, their people and the planet.”

- Brendan Gibbs, Senior Vice President of Automated WAN Solutions, Juniper Networks

“Digital transformation is moving into its next phase which is all about transforming operational technology (OT) and driving the distributed delivery of new applications and use cases based on emerging technologies such as AI and AR. The metro edge is key to supporting the massive data, real-time performance and sustainability demands that this new era of OT transformation is bringing. This important industry shift requires the re-imagining and re-engineering of the metro network and Juniper is showing leadership here in its Cloud Metro portfolio. Service providers that want to deliver reliable, secure and high-performing services at the metro edge with a sustainable business model should pay close attention.”

- Caroline Chappell, Research Director, Cloud Practice, Analysys Mason

“Our metro connectivity services across more than 260 major cities around the world meet our customers’ need for secure, scalable and high-performance networking. We experience continuous demand for secure connectivity and expect to see double-digit traffic growth on our network, as we continue to provide the great experience our customers require. We’re long-term supporters of Juniper’s vision for high-performance, scalable IP networking and are excited to see the significant enhancements and innovation featured in their Cloud Metro portfolio that can bring more benefits for our customers in the future.”

- Don MacNeil, Chief Operating Officer, GTT Communications

“We are excited that the partnership between Broadcom and Juniper has delivered such a comprehensive portfolio of WAN routing platforms, all based on our leading Jericho and Qumran silicon. This announcement is especially compelling as it showcases Broadcom’s Jericho 2c+ silicon enabling a 50 percent increase to the industry’s highest-density 400G routing line card in a modular chassis. With market-leading 54 ports of 400G per slot at 21.6Tbps, this performance underscores the unmatched scalability and power efficiency of the product offering. We are thankful for our engineering teams.”

- Ram Velaga, Senior Vice President and General Manager, Core Switching Group, Broadcom

Solution Availability

¹AI-enabled Paragon Automation-as-a-Service – available 1H23
²ACX7000 Family:

  • ACX7100-32C, ACX7100-48L, ACX7509 – available now
  • ACX7024 – orderable now, available Q3’22
  • ACX7908, ACX7348 – orderable 1H’23

³Juniper embedded Paragon Active Assurance – available 2H’22
Built-in zero trust security with SaaS-based network trust attestation – available 1H’23
⁵Juniper 400G ZR/ZR+ optics – orderable & available Q3’22

Additional Resources

Cloud Metro Solution Page
Blog: Cloud Metro: Reimagining Metro Networks for Sustainable Business Growth
Blog: Welcome to the Future of Network Automation: Juniper Paragon Automation-as-a-Service
Blog: Reimagining Metro Architectures for the Experience-First Era
Blog: Balancing Design Choices for Sustainable Growth: Juniper ACX7000 Family
ACX7000 Family Datasheet
Solution Brief: Juniper Cloud Metro as the Experience Sensor
Solution Brief: AI-Enabled Device Onboarding as a Service
Demo: Paragon Automation as a Service Device Onboarding

About Juniper Networks
Juniper Networks is dedicated to dramatically simplifying network operations and driving superior experiences for end users. Our solutions deliver industry-leading insight, automation, security and AI to drive real business results. We believe that powering connections will bring us closer together while empowering us all to solve the world’s greatest challenges of well-being, sustainability and equality. Additional information can be found at Juniper Networks (www.juniper.net ) or connect with Juniper on Twitter , LinkedIn and Facebook .

Juniper Networks, the Juniper Networks logo, Juniper, Junos, and other trademarks listed here are registered trademarks of Juniper Networks, Inc. and/or its affiliates in the United States and other countries. Other names may be trademarks of their respective owners.

Statement of Product Direction
The information on this page may contain Juniper's development and plans for future products, features, or enhancements ("SOPD Information"). SOPD Information is subject to change at any time, without notice. Juniper provides no assurances, and assumes no responsibility, that future products, features, or enhancements will be introduced. In no event should any purchase decision be based upon reliance of timeframes or specifics outlined as part of SOPD Information, because Juniper may delay or never introduce the future products, features, or enhancements.

Any SOPD Information within, or referenced or obtained from, this website by any person does not give rise to any reliance claim, or any estoppel, against Juniper in connection with, or arising out of, any representations set forth in the SOPD Information. Juniper is not liable for any loss or damage (howsoever incurred) by any person in connection with, or arising out of, any representations set forth in the SOPD Information.

category-serviceprovider

Link:

ClickThru

Social Media:

https://www.facebook.com/JuniperNetworks/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 11:07:00 CET | Press release

Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,

ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 10:00:00 CET | Press release

CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including

I Squared Capital Acquires Ramudden Global, a Leader in Traffic Management and Infrastructure Safety7.1.2026 09:00:00 CET | Press release

Acquisition will accelerate Ramudden’s ambitious growth plan across North America and Europe supported by strong infrastructure spending tailwinds I Squared Capital, a leading global infrastructure investment manager, today announced that, through its flagship fund, it has agreed to acquire Ramudden Global, from funds advised by Triton Partners (“Triton”), a leading European mid-market sector-specialist investor. Ramudden Global is a leading international provider of traffic management and infrastructure safety services supporting the maintenance and upgrade of essential transport and utility networks. The company operates more than 190 depots across 13 countries in Europe and North America delivering mission-critical services that help to ensure safety, regulatory compliance and continuity of service across road, utility and broader infrastructure works. This investment underscores I Squared Capital’s commitment to investing in essential, regulated, infrastructure businesses that unde

RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta7.1.2026 09:00:00 CET | Press release

RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and BOOST Pharma, a clinical-stage biotechnology company developing first-in-class cell therapies for rare paediatric skeletal diseases, today announced a strategic manufacturing partnership to support the development of BOOST Pharma’s cell therapy, BT-101, for the treatment of infants with Osteogenesis Imperfecta (OI), also known as brittle bone disease. Under the service agreement, BOOST Pharma has transferred its manufacturing process to RoslinCT’s state-of-the-art facilities in Edinburgh, Scotland. The partnership will progress toward GMP manufacturing of starting materials and clinical drug product, supporting Phase III clinical development of BT-101. The therapy is an allogeneic mesenchymal stem cell (MSC) product designed to address the underlying cause of OI at the earliest stages of life. BOOST Pharma was founded on pioneering science originating from Karolins

Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA® Commercialization in Central and Eastern Europe7.1.2026 08:30:00 CET | Press release

Exclusive agreement covers 13 Central and Eastern European markets Collaboration will help expand access to VANFLYTA for patients with newly diagnosed FLT3-ITD positive AML Daiichi Sankyo (TSE: 4568) and GENESIS Pharma have entered into an exclusive license and supply agreement for the distribution and commercialization of VANFLYTA® (quizartinib) in 13 markets across Central and Eastern Europe for the treatment of adult patients with newly diagnosed FLT3-ITD positive acute myeloid leukemia (AML). Under the terms of the agreement, Daiichi Sankyo will be responsible for the manufacturing and supply of VANFLYTA while GENESIS Pharma will lead medical affairs, market access and commercialization efforts in Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia and Slovenia. Financial terms of the agreement are not being disclosed. VANFLYTA was approved in the EU in November 2023 for the treatment of adult patients with newly diagnose

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye